6758.TWO A-SPINE Asia Co., Ltd.
- Market cap
- TWD 413M
- P/E
- 43.8x
- P/B
- 1.56x
- ROE
- 5.5%
- Dividend yield
- 3.26%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 6758.TWO undervalued?
Graham number6758.TWO trades 74.5% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
A-SPINE Asia Co., Ltd. fundamental analysis
No fundamental analysis for A-SPINE Asia Co., Ltd. yet.
A-SPINE Asia Co., Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About A-SPINE Asia Co., Ltd.
A-SPINE Asia Co., Ltd., a medical device company, engages in the research, development, manufacture, and marketing of spinal implants and instruments in Taiwan, China, the Philippines, Australia, New Zealand, Iran, Vietnam, Indonesia, Spain, Trinidad, and Sri Lanka. The company offers spinal fixation systems, such as cervical anterior fixation, and thoracic and lumbar fixation systems; interbody fixation systems, including ACDF cages, PLIF/TLIF cages, and ALIF cages; balloon…
Full company profileA-SPINE Asia Co., Ltd. financial statements
A-SPINE Asia Co., Ltd. annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 340M | 412M | 400M | 431M | 370M | 310M | 330M | 391M | 405M | 449M |
| Gross Profit | 265M | 322M | 314M | 326M | 287M | 235M | 230M | 292M | 305M | 332M |
| Operating Income | 51.4M | 72.5M | 62.7M | 72.1M | 33.0M | 20.9M | 7.73M | 11.1M | 7.80M | 18.4M |
| EBITDA | 57.1M | 80.2M | 73.6M | 81.4M | 48.9M | 38.4M | 27.9M | 29.8M | 26.9M | 34.5M |
| Net Income | 43.7M | 59.4M | 50.1M | 70.7M | 30.4M | 17.7M | 8.01M | 9.21M | 8.41M | 15.1M |
| EPS | 3.48 | 4.73 | 3.97 | 5.22 | 2.25 | 1.31 | 0.59 | 0.68 | 0.62 | 1.12 |
| Balance Sheet | ||||||||||
| Total Assets | - | - | - | - | 542M | 500M | 511M | 515M | 507M | 520M |
| Total Liabilities | - | - | - | 777K | 244M | 210M | 234M | 241M | 236M | 245M |
| Shareholders' Equity | - | - | - | - | 299M | 289M | 277M | 274M | 271M | 274M |
| Cash & Short-term Investments | - | - | - | - | 65.2M | 65.0M | 82.5M | 54.3M | 48.0M | 56.6M |
| Total Debt | - | - | - | - | 126M | 119M | 147M | 136M | 133M | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | - | - | - | 42.0M | 33.2M | 35.0M | 18.3M | 3.96M | 17.5M | 29.7M |
| Capital Expenditure | - | - | - | 18.7M | 6.10M | 2.95M | 4.61M | 3.47M | 4.51M | 1.57M |
| Free Cash Flow | - | - | - | 23.3M | 27.1M | 32.0M | 13.7M | 487K | 13.0M | 28.2M |
| Ratios | ||||||||||
| ROE | - | - | - | - | 10.2% | 6.1% | 2.9% | 3.4% | 3.1% | 5.5% |
| ROA | - | - | - | - | 5.6% | 3.6% | 1.6% | 1.8% | 1.7% | 2.9% |
| Net Profit Margin | 12.9% | 14.4% | 12.5% | 16.4% | 8.2% | 5.7% | 2.4% | 2.4% | 2.1% | 3.4% |
| Debt to Equity | - | - | - | - | 0.42x | 0.41x | 0.53x | 0.50x | 0.49x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
A-SPINE Asia Co., Ltd. dividends
- Dividend yield
- 3.26%
- Forward dividend
- 1.00 TWD
- Payout ratio
- 89.3%
- Ex-dividend date
- Aug 4, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | TWD 13.5M | 1.00 | 89.3% |
| 2024 | TWD 13.5M | 1.00 | 160.2% |
| 2023 | TWD 13.5M | 0.99 | 146.3% |
| 2022 | TWD 20.2M | 1.49 | 252.3% |
| 2021 | TWD 26.9M | 1.99 | 151.9% |
| 2020 | 33.7M | 2.49 | 110.8% |
| 2019 | 32.3M | 2.39 | 45.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns A-SPINE Asia Co., Ltd.
Ownership data of A-SPINE Asia Co., Ltd. is not available yet.
A-SPINE Asia Co., Ltd. company profile
- Company name
- A-SPINE Asia Co., Ltd.
- Ticker
- 6758.TWO
- ISIN
- TW0006758006
- Exchange
- Taiwan OTC Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Fiscal year end
- December
- Address
- No. 80, Chenggong Road, New Taipei City, Taiwan, 234
- Phone
- 886 2 2926 7088
- Website
- aspine.com.tw
About A-SPINE Asia Co., Ltd.
A-SPINE Asia Co., Ltd., a medical device company, engages in the research, development, manufacture, and marketing of spinal implants and instruments in Taiwan, China, the Philippines, Australia, New Zealand, Iran, Vietnam, Indonesia, Spain, Trinidad, and Sri Lanka. The company offers spinal fixation systems, such as cervical anterior fixation, and thoracic and lumbar fixation systems; interbody fixation systems, including ACDF cages, PLIF/TLIF cages, and ALIF cages; balloon kyphoplasty products; and vertebral body replacement products. It sells imported orthopedic medical devices. A-SPINE Asia Co., Ltd.was founded in 2001 and is based in New Taipei City, Taiwan.